maryam abdullahi

maryam abdullahi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
YJYusuf Jimoh
Yusuf Jimoh
IAIdris Yunusa Abdullah
Idris Yunusa Abdullah
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
MAmaryam abdullahi
maryam abdullahi
AOAhmadu Jibril Oludare
Ahmadu Jibril Oludare
ZSZukhruf Salami
Zukhruf Salami
Malaria, a devastating disease caused by Plasmodium parasites, continues to pose a significant threat to global health, with increasing resistance to current antimalarial drugs. In this study, we employed an in silico approach to design and evaluate novel 2-pyrazoline carboxamide derivatives as potential protease inhibitors against Plasmodium falciparum. Our results show that all the designed ligands exhibit good drug-like properties, satisfying Lipinski’s rule of five, and have low toxicity profiles. Molecular docking studies revealed that five newly designed ligands (P5, P6, P7, P11, and P13) exhibit promising binding affinities and interactions with key protease enzymes involved in the hemoglobin degradation pathway, including Falcipain-2, Falcipain-3, and Plasmepsin-2 with PDB (Protein Data Bank) codes of 6JW9, 3BWK, and 1LF3, respectively. Notably, ligand P13 showed the strongest binding affinity with Falcipain-2, forming an additional hydrogen bond with CYS42, an essential residue for the enzyme’s catalytic activity. The interactions between the ligands and the enzymes suggest a competitive inhibition mechanism, with the potential to disrupt the hemoglobin degradation pathway and halt the parasite’s lifecycle. The biological implications of these findings are significant, as they suggest that these novel ligands could be effective against Plasmodium parasites, particularly in the context of increasing resistance to current antimalarial drugs. Overall, this study provides valuable insights into the potential of novel 2-pyrazoline carboxamide derivatives to serve as protease inhibitors against Plasmodium parasites, highlights their potential as a promising strategy for antimalarial drug development, and demonstrates the importance of in silico approaches in the discovery of novel therapeutics.

14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
HBHASSAN ALI BILA
HASSAN ALI BILA
BBBashar Bawa
Bashar Bawa
MAmaryam abdullahi
maryam abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HSHassan Halimatu Sadiya
Hassan Halimatu Sadiya
Malaria remains a critical global health challenge, particularly affecting Sub-Saharan Africa. Plasmepsins, vital in hydrolyzing peptide bonds within proteins, present promising targets for antimalarial drugs. Plasmepsins I and II, key aspartic proteases, are crucial in various parasite processes. This study investigates the inhibitory properties of quercetin, quercetrin, dihydrostilbene, 4′-methoxy-isoliquiritigenin, and stigmasterol from Globimetula oreophila on plasmepsins through in silico techniques, including ADME predictions and molecular docking. Results reveal strong interactions of these compounds with active site residues, with quercetrin and stigmasterol displaying notable binding affinities. These findings suggest the potential of G. oreophila metabolites as potent plasmepsin inhibitors, offering prospects for malaria treatment and prevention.

14 November 2024 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
HKHamza Karimatu
Hamza Karimatu
IYIdris Abdullahi Yunusa
Idris Abdullahi Yunusa
MMMuhammad Aliyu Musa
Muhammad Aliyu Musa
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HAHamza Sa’adatu Auwal
Hamza Sa’adatu Auwal
MAmaryam abdullahi
maryam abdullahi
Throughout history to the present day, infectious diseases have been a persistent global threat, causing significant harm to public health and economic stability. To address these challenges, the development of novel antimicrobial drugs is crucial. Hydrazones have gained significant attention in the scientific literature as promising candidates for developing new antimicrobial drugs. Two new hydrazones (H3 and H4) incorporating moieties that are known to enhance antimicrobial activity were synthesized. Methods: Hydrazone derivatives were synthesized through a condensation reaction of substituted acetophenone and nitro phenyl hydrazine. The compounds were characterized by their melting points and spectral analyses, including FT-IR, 1H NMR, 13C NMR, and 2D NMR. Their antibacterial effects on Escherichia coli and Staphylococcus aureus were assessed in-vitro using the agar diffusion and broth dilution methods. Results: In-vitro testing demonstrated the compounds’ good activity against the tested organisms, particularly Gram-positive bacteria. At a concentration of 50 mg/mL, H3 produced a zone of inhibition (19 mm) comparable to that of the standard ciprofloxacin (20 mm) at 0.05 mg/mL. Only H3 was able to kill both Staphylococcus aureus and Escherichia coli at a concentration of 50 mg/mL. In all cases, H3 was found to be the most effective with optimum bactericidal and bacteriostatic activity against staphylococcus aureus and Escherichia coli. Conclusions: All the synthesized compounds were proven to possess promising antibacterial activity in vitro against the tested organisms.

2 July 2025 in Sciences of Phytochemistry
Verified
Journal Article
Open access
PDF file
DAUDA GARBADAUDA GARBA
DAUDA GARBA
BABila Hassan Ali
Bila Hassan Ali
BBBashar Bawa
Bashar Bawa
MAmaryam abdullahi
maryam abdullahi
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
HHHalimatu Sadiya Hassan
Halimatu Sadiya Hassan
Malaria remains a major global health challenge due to its high morbidity and mortality, further complicated by growing antimalarial drug resistance. Natural products are being increasingly explored as potential sources of new therapies, with malarial proteases emerging as promising targets due to their essential roles in parasite development, invasion, egress, and hemoglobin degradation. This study evaluates the inhibitory potential of five compounds, quercetrin (DG1), dihydrostilbene (DG2), 4′-methoxy-isoliquiritigenin (DG3), stigmasterol (DG4), and quercetin (DG5), isolated from Globimetula oreophila leaves, using in silico docking against Plasmodium falciparum enzymes. Targets included falcipain-2 and falcipain-3 (cysteine proteases), SERA5 (hemoglobin-processing enzyme), PfDHFR-TS (bifunctional enzyme), and PfCDPK2 (kinase). Docking revealed strong binding affinities through hydrogen bonds, van der Waals forces, and hydrophobic interactions. DG4 showed a high affinity for PfDHFR (-10.3 kcal/mol), comparable to cycloguanil (-10.7 kcal/mol), while DG1 bound firmly to falcipain-2 (-7.9 kcal/mol), falcipain-3 (-7.5 kcal/mol), and PfCDPK2 (-9.0 kcal/mol). Binding to SERA5 ranged from -6.0 to -6.8 kcal/mol. These findings suggest that the tested compounds may act as inhibitors of vital P. falciparum enzymes, holding promise for the development of antimalarial drugs.

13 November 2025 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
EOEnayi Onaji
Enayi Onaji
YJYusuf Jimoh
Yusuf Jimoh
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
MAmaryam abdullahi
maryam abdullahi
Triple-negative breast cancer (TNBC) accounts for approximately 10–15% of breast cancer cases and poses a significant clinical challenge due to its aggressive nature and poorer survival outcomes compared to other subtypes. This is primarily attributed to the lack of estrogen, progesterone, and HER2 receptors, which render conventional hormone-based therapies ineffective. In this study, we employed in silico approaches to design and evaluate novel chalcone derivatives as potential inhibitors of Lyn tyrosine kinase, a critical enzyme implicated in TNBC progression. The designed compounds were screened for drug-likeness and toxicity, all meeting Lipinski’s rule of five and demonstrating favorable toxicity profiles. Molecular docking analyses identified five promising ligands, CHCN1, CHCN19, CHCN48, CHCN333, and CHCN94, that exhibited comparable binding affinities to key active site residues of Lyn kinase, including Asp385, Phe386, Gly387, Lys275, and Glu290. Among these, CHCN1 showed the highest binding affinity at –8.4 kcal/mol, likely due to interactions with Asp385 and Lys275. These results suggest that the chalcone derivatives may effectively disrupt Lyn-mediated signaling pathways essential for cancer cell survival, potentially inhibiting proliferation, metastasis, and invasion. Overall, this study provides valuable insights into the therapeutic potential of chalcone derivatives for TNBC, offering promising avenues for targeted intervention.

20 November 2025 in Chemistry Proceedings
Verified
Conference Paper
Open access
PDF file
AYAbubakar Sadiq Yakubu
Abubakar Sadiq Yakubu
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
IAIdris Yunusa Abdullahi
Idris Yunusa Abdullahi
MAmaryam abdullahi
maryam abdullahi
Idris AbdullahiIdris Abdullahi
Idris Abdullahi
IAIDRIS UMAR ALFULANII
IDRIS UMAR ALFULANII
Depression is a debilitating neuropsychiatric disorder and a leading cause of disability worldwide, with current therapeutic options often limited by delayed onset of action, inadequate efficacy, and undesirable side effects. The quinoline scaffold, a privileged structure in medicinal chemistry, has been reported to possess a wide spectrum of pharmacological properties, including central nervous system (CNS) modulation. In this study, two novel 2,4-diphenylquinoline derivatives—CMPD1 [2-(4-methoxyphenyl)-4-phenylquinoline] and CMPD2 [2-(2,4-dichlorophenyl)-4-phenylquinoline]—were rationally designed based on structure–activity relationship (SAR) insights and synthesized via the Friedländer condensation of appropriately substituted anilines with carbonyl precursors. Purification was achieved through recrystallization, and structural confirmation was performed using Fourier-transform infrared (FT-IR) spectroscopy, proton nuclear magnetic resonance (NMR), and carbon-13 NMR spectroscopy, confirming the expected chemical shifts and diagnostic signals for quinoline derivatives. The pharmacological activity was evaluated using murine models for antidepressant screening: the Forced Swim Test (FST) and Tail Suspension Test (TST). Both compounds produced statistically significant reductions in immobility time compared to the control group (p < 0.05), with CMPD2 showing slightly enhanced activity. The results suggest that electron-donating and electron-withdrawing substituents influence antidepressant potency, potentially through modulation of CNS receptor binding. These findings validate 2,4-diphenylquinoline derivatives as promising antidepressant leads, meriting further optimization, in vivo pharmacokinetic studies, and mechanistic investigations to establish their clinical translation potential.